Talphera Stock Investor Sentiment

TLPH Stock   0.64  0.02  3.23%   
Under 72 percent of all Talphera's traders are curious in acquiring. The analysis of overall sentiment of trading Talphera stock suggests that a large number of investors are confidant at this time. Talphera's investing sentiment shows overall attitude of investors towards Talphera.
  
over six months ago at news.google.com         
Talphera to Release Earnings on Wednesday - American Banking and Market News - AmericanBankingNEWS
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by Dasu Badri N of 14667 shares of TALPHERA INC subject to Rule 16b-3
Macroaxis News
over six months ago at finance.yahoo.com         
Sale by Wan Mark A of 16049 shares of TALPHERA INC
Yahoo News
over six months ago at finance.yahoo.com         
Talphera to Host Fourth Quarter and Full-Year 2023 Financial Results Call and Webcast on March 6, 20...
Yahoo News
over six months ago at www.macroaxis.com         
Acquisition by Wrightmitchell Jane of 79500 shares of TALPHERA INC subject to Rule 16b-3
Macroaxis News
over six months ago at thelincolnianonline.com         
Conversion by Three Arch Management Iv Llc of tradable shares of TALPHERA INC
news
over six months ago at thelincolnianonline.com         
StockNews.com Begins Coverage on AcelRx Pharmaceuticals
news
over six months ago at www.macroaxis.com         
Acquisition by Angotti Vincent J. of 58667 shares of TALPHERA INC subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Talphera Inc. Soars with Impressive Sales Surge and Insider Buying - BNN Breaking
Google News at Macroaxis
over six months ago at news.google.com         
Healthcare Stocks Moving Up and Down Monday RNLX, TTOO, CBAY, TLPH, ANTX, TCBP, IVVD, BDSX - Investo...
Google News at Macroaxis
over six months ago at thelincolnianonline.com         
AcelRx Pharmaceuticals Earns Sell Rating from Analysts at StockNews.com
news
over six months ago at seekingalpha.com         
Talphera files to sell 7.79M shares for its holders
seekingalpha News
over six months ago at thelincolnianonline.com         
AcelRx Pharmaceuticals Coverage Initiated at StockNews.com
news
over six months ago at news.google.com         
Why Sintx Technologies Shares Are Trading Higher By Over Here Are 20 Stocks Moving Premarket By Benz...
Google News at Macroaxis
over six months ago at thelincolnianonline.com         
Talphera Given New 6.00 Price Target at HC Wainwright
news
Far too much social signal, news, headlines, and media speculation about Talphera that are available to investors today. That information is available publicly through Talphera media outlets and privately through word of mouth or via Talphera internal channels. However, regardless of the origin, that massive amount of Talphera data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Talphera news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Talphera relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Talphera's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Talphera alpha.

Talphera Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Insider Trading
10/01/2024
2
Disposition of 1623 shares by Vincent Angotti of Talphera at 1.3 subject to Rule 16b-3
10/25/2024
3
Talphera Upgraded by Maxim Group to Strong-Buy Rating
11/12/2024
4
AcelRx Pharmaceuticals GAAP EPS of -0.13 beats by 0.07
11/13/2024
5
Talphera, Inc. Q3 2024 Earnings Call Transcript
11/15/2024
6
Acquisition by Vincent Angotti of 5000 shares of Talphera at 0.7299 subject to Rule 16b-3
11/27/2024
7
Talphera CEO Vincent J. Angotti buys 3,649 in company stock
12/02/2024
8
Acquisition by Vincent Angotti of 5000 shares of Talphera at 0.6399 subject to Rule 16b-3
12/05/2024

Complementary Tools for Talphera Stock analysis

When running Talphera's price analysis, check to measure Talphera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Talphera is operating at the current time. Most of Talphera's value examination focuses on studying past and present price action to predict the probability of Talphera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Talphera's price. Additionally, you may evaluate how the addition of Talphera to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stocks Directory
Find actively traded stocks across global markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation